PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 185 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $684,000 | +4.0% | 14,328 | -0.8% | 0.00% | 0.0% |
| Q1 2017 | $658,000 | +69.6% | 14,437 | +19.8% | 0.00% | +100.0% |
| Q4 2016 | $388,000 | -6.5% | 12,052 | -0.7% | 0.00% | -33.3% |
| Q3 2016 | $415,000 | -35.8% | 12,143 | -36.7% | 0.00% | -25.0% |
| Q2 2016 | $646,000 | +113.2% | 19,180 | +234.6% | 0.00% | +100.0% |
| Q1 2016 | $303,000 | -79.2% | 5,732 | -72.5% | 0.00% | -60.0% |
| Q1 2014 | $1,458,000 | – | 20,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |